Patent Application
20240025841
The presently claimed invention relates to a method for obtaining crystalline diethylamino hydroxybenzoyl hexyl benzoate. Further, the presently claimed invention relates to crystalline diethylamino hydroxybenzoyl hexyl benzoate obtained by the method and to a cosmetic composition comprising crystalline diethylamino hydroxybenzoyl hexyl benzoate.
UV radiation causes harmful effects on the human skin such as sunburn, phototoxic and photo allergenic reactions, acceleration of skin aging and increase in the risk of skin cancer.
To protect the human skin from UV radiation, sunscreen or cosmetic compositions comprising UV filters (also referred to as UV absorbers) are used.
In general, UV light can be divided into UV-A radiation (320-400 nm) and UV-B radiation (280-320 nm). Since 2006, the EU commission has recommended that all sunscreen or cosmetic compositions should have an UV-A protection factor, which is at least one third of the labelled sun protection factor (SPF), wherein the sun protection factor refers mainly to the UV-B protection.
2-(4′-Diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester is an effective UV-A filter. It is represented by formula (I).
2-(4′-Diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I) preparation is known, e.g. from DE 10011317, EP2155660, and WO 2003097578.
However, the product obtained from known processes are associated with several disadvantages.
Generally, 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I) is obtained as a melt after the completion of synthesis process and it stored in the same form. Crystal growth occurs in the melt after about six weeks at room temperature. At the time of use, the user is required to heat the entire pack to a temperature above the melting point of (I) to be able to remove product from the storage containers.
The product contains phthalic acid dihexyl ester (II) (also known as PSDHE, dihexylphthalate) as an impurity. The PSDHE content should be as low as possible, since this substance is toxic; it can damage fertility and may have harmful effects on the unborn child. According to the harmonized classification and labelling (ATP05), the allowable amount of PSDHE (II) in the final product is up to 150 ppm.
Further, the product obtained by known processes contains rhodamine B type dyes (e.g. [9-(2-carboxyphenyl)-6-diethylamino-3-xanthenylidene]-diethylammonium salts) (Ill) and corresponding esters (IV) as impurities, which lead to an undesired discoloration of the final product.
Due to these challenges, there is an ongoing need for a fast and efficient method for obtaining crystalline 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I) as well as obtaining crystalline (I) having a low amount of (II), and low amounts of (Ill) and (IV).
Accordingly, it is an object of the present invention to provide a method for obtaining crystalline 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I). Further, it is an object to provide a method to obtain crystalline 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I) having a low amount of phthalic acid dihexyl ester (II). Furthermore, it is desired that the method provides crystalline 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester having low amounts of rhodamine based impurities (Ill) and (IV).
Surprisingly, it is found that at least one of the above objects is achieved by the method according to the presently claimed invention. The method of the presently claimed invention provides crystalline 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I) having a low PSDHE (II) content (in the range of 1 to 250 ppm), a low rhodamine (Ill) content (the range of 1 to 100 ppm) and a low rhodamine hexyl ester (IV) content (the range of 1 to 120 ppm).
Thus, an aspect of the presently claimed invention directed to a method for obtaining crystalline diethylamino hydroxybenzoyl hexyl benzoate (I); the method comprises steps (a) to (d),
In a preferred embodiment, the method for obtaining crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) comprises steps (a) to (d),
Another aspect of the presently claimed invention is directed to crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) obtained by the method described above.
Another aspect of the presently claimed invention is directed to the crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) obtained by the method of the presently claimed invention having a phthalic acid dihexyl ester (PSDHE) content in the range of 1 to 250 ppm, based on the weight of the crystalline diethylamino hydroxybenzoyl hexyl benzoate (I).
The crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) has
The disclosure described herein is illustrated by way of example and not by way of limitation in the accompanying figures.
Before the present compositions and formulations of the presently claimed invention are described, it is to be understood that this invention is not limited to particular compositions and formulations described, since such compositions and formulation may, of course, vary. It is also to be understood that the terminology used herein is not intended to be limiting, since the scope of the presently claimed invention will be limited only by the appended claims.
If hereinafter a group is defined to comprise at least a certain number of embodiments, this is meant to also encompass a group which preferably consists of these embodiments only.
Furthermore, the terms ‘first’, ‘second’, ‘third’ or ‘a’, ‘b’, ‘c’, etc. and the like in the description and in the claims, are used for distinguishing between similar elements and not necessarily for describing a sequential or chronological order. It is to be understood that the terms so used are interchangeable under appropriate circumstances and that the embodiments of the presently claimed invention described herein are capable of operation in other sequences than described or illustrated herein. In case the terms ‘first’, ‘second’, ‘third’ or ‘(A)’, ‘(B)’ and ‘(C)’ or ‘(a)’, ‘(b)’, ‘(c)’, ‘(d)’, ‘i’, ‘ii’ etc. relate to steps of a method or use or assay there is no time or time interval coherence between the steps, that is, the steps may be carried out simultaneously or there may be time intervals of seconds, minutes, hours, days, weeks, months or even years between such steps, unless otherwise indicated in the application as set forth herein above or below.
Furthermore, the ranges defined throughout the specification include the end values as well i.e. a range of 1 to 10 implies that both 1 and 10 are included in the range. For the avoidance of doubt, applicant shall be entitled to any equivalents according to applicable law.
In the following passages, different aspects of the presently claimed invention are defined in more detail. Each aspect so defined may be combined with any other aspect or aspects unless clearly indicated to the contrary. In particular, any feature indicated as being preferred or advantageous may be combined with any other feature or features indicated as being preferred or advantageous.
Reference throughout this specification to ‘one embodiment’ or ‘an embodiment’ means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment of the presently claimed invention. Thus, appearances of the phrases ‘in one embodiment’ or ‘in an embodiment’ in various places throughout this specification are not necessarily all referring to the same embodiment.
Furthermore, the particular features, structures or characteristics may be combined in any suitable manner, as would be apparent to a person skilled in the art from this disclosure, in one or more embodiments. Furthermore, while some embodiments described herein include some, but not other features included in other embodiments, combinations of features of different embodiments are meant to be within the scope of the presently claimed invention, and form different embodiments, as would be understood by those in the art. For example, in the appended claims, any of the claimed embodiments can be used in any combination.
Surprisingly, it is found that the method according to the presently claimed invention provides crystalline 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I) having a low PSDHE (II) content as well as low content of rhodamine based impurities (Ill) and (IV). The method of the presently claimed invention is fast and efficient.
The method of the presently claimed invention improves the quality and purity of crystalline (I) and reduces the time required for the crystallization by selection of appropriate crystallization process parameters such as crystallization solvent, degree of supersaturation, the amount of seed crystals of (I), the temperature of seeding and the temperature as well as time of each process step.
Accordingly, an aspect of the presently claimed invention is directed to a method for obtaining crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) comprising steps (a) to (d),
The term “ultraviolet filter” or “UV filter” as used herein refers to organic or inorganic compounds, which can absorb and/or reflect UV radiation caused by sunlight. UV filter can be classified based on their UV protection curve as UV-A, UV-B or broadband filters. In the context of the present application, broadband filters may be listed as UV-A filters, as they also provide UV-A protection. In other words, preferred UV-A filters also include broadband filters.
The definition of “broadband” protection (also referred to as broad-spectrum or broad protection) is based on the “critical wavelength”. For broadband coverage, UV-B and UV-A protection must be provided. According to the US requirements, a critical wavelength of at least 370 nm is required for achieving broad spectrum protection. Furthermore, it is recommended by the European Commission that all sunscreen or cosmetic compositions should have an UVA protection factor, which is at least one third of the labelled sun protection factor (SPF), e.g. if the sunscreen composition has an SPF of 30, the UVA protection factor has to be at least 10.
The term “sunscreen composition” or “sunscreen” or “skin-care product” refers to any topical product, which reflects and/or absorbs certain parts of UV radiation. Thus, the term “sunscreen composition” is to be understood as not only including sunscreen compositions, but also any cosmetic compositions that provide UV protection. The term “topical product” refers to a product that is applied to the skin and can refer, e.g., to sprays, lotions, creams, oils, foams, powders, or gels. According to the present invention the sunscreen composition may comprise one or more active agents, e.g., organic UV filters, as well as other ingredients or additives, e.g., emulsifiers, emollients, viscosity regulators, stabilizers, preservatives, or fragrances.
In a preferred embodiment, the method for obtaining crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) comprises steps (a) to (d),
In a preferred embodiment, the method for obtaining crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) involves the recrystallization step. Thus, the process comprises steps (a) to (e),
In a preferred embodiment, the crystallization solvent is at least one selected from the group consisting of C4-C8 alcohols.
In a preferred embodiment, the crystallization solvent is 1-hexanol.
In general, the last step of the synthesis of diethylamino hydroxybenzoyl hexyl benzoate (I) is esterification of diethylamino hydroxybenzoyl benzoic acid with 1-hexanol. The product obtained from the esterification step comprises a mixture of diethylamino hydroxybenzoyl hexyl benzoate (I) and 1-hexanol.
In a preferred embodiment, the product obtained from the esterification comprising diethylamino hydroxybenzoyl hexyl benzoate (I) and 1-hexanol is directly used as a feed for the crystallization.
In a preferred embodiment, the amount of (I) in the feed is in the range of 15.0 and 65.0 wt %, more preferably in the range of 25.0 to 60.0 wt %, even more preferably in the range of 35.0 to 50.0 wt %, most preferably in the range of 40.0 to 50.0 wt %, and in particular preferably in the range of 45.0 to 49.0 wt % based on the total weight of the feed.
In a preferred embodiment, the amount of 1-hexanol in the feed is in the range of 35.0 to 85.0 wt %, more preferably in the range of 40.0 to 75.0 wt %, most preferably in the range of 50.0 to 65.0%, and in particular preferably in the range from 50.0 to 60.0 wt %, based on the total weight of the feed.
The feed also contains impurities.
In a preferred embodiment, the amount of phthalic acid dihexyl ester (PSDHE) (II) in the feed is in the range of 8000 to 20000 ppm and more preferably in the range of 12000 to 18000 ppm based on the weight of diethylamino hydroxybenzoyl hexyl benzoate (I).
In a preferred embodiment, the amount of rhodamine (Ill) in the feed is in the range of 500 to 6000 ppm and more preferably in the range of 1000 to 4000 ppm based on the weight of diethylamino hydroxybenzoyl hexyl benzoate (I).
In a preferred embodiment, the amount of rhodamine hexyl ester (IV) in the range of 1000 to 10000 ppm and more preferably in the range of 5000 to 10000 ppm based on the weight of diethylamino hydroxybenzoyl hexyl benzoate (I).
In a preferred embodiment, an additional amount of 1-hexanol is mixed with the product obtained from the esterification comprising diethylamino hydroxybenzoyl hexyl benzoate (I) and 1-hexanol to obtain feed. The amount of 1-hexanol required depends upon the concentration of (I) to be achieved in the feed in step (a).
In a preferred embodiment, in step (a) the feed is heated to a temperature in the range of 25 to 80° C. In a more preferred embodiment, in step (a) the feed is heated to a temperature in the range of 35 to 80° C., most preferably in the range of 35 to 60° C. and in particular preferably in the range of 38 to 60° C.
In a preferred embodiment, in step (a) the feed is heated to 48° C.
In a preferred embodiment, in step (a) the feed is heated to 49° C.
In a preferred embodiment, in step (b) the solution is cooled to a temperature in the range of by 18 to 35° C., more preferably in the range of 18 to 30° C. and most preferably in the range of 18 to 28° C.
In a preferred embodiment, in step (b) the solution is cooled to 25° C.
In a preferred embodiment, in step (b) the solution is cooled to 26° C.
Degree of Supersaturation
The degree of supersaturation (c:c*) is an important aspect of the crystallization process of the presently claimed invention.
In a preferred embodiment, the ratio of c:c* is in the range from 1.1:1.0 to 9.0:1.0, more preferably in the range of 1.5:1.0 to 7.0:1.0 and most preferably in the range from 2.0:1.0 to 6.0:1.0.
In a preferred embodiment, the ratio of c:c* is 3.8:1.0.
In a preferred embodiment, the ratio of c:c* is 4.0:1.0.
In a preferred embodiment, the ratio of c:c* is 4.1:1.0.
Seeding
The crystallization of (I) on its own is very slow due to the high metastable character of liquid (I). Seeding of the supersaturated solution is an important step during the crystallization of the presently claimed invention. Due to seeding, the crystallization starts early as compared to that without seed crystals. Hence, the overall process of the presently claimed invention provides crystalline (I) faster as compared to a process that does not involve the step of seeding.
In addition to the other process parameters, carrying out the seeding at a right temperature and using a right amount of crystals of (I) followed by the stirring at the temperature of seeding are important for the success of the presently claimed invention.
The quality of crystalline (I) obtained during the crystallization depends upon the temperature at which seeding is carried out as well as upon the amount of seed crystals.
In a preferred embodiment, in step (c) the seeding is carried out at a temperature in the range of 18 to 35° C., more preferably in the range of 18 to 30° C. and most preferably in the range of 18 to 28° C.
In a preferred embodiment, in step (c) the seeding is carried out at 25° C.
In a preferred embodiment, the seed crystals of diethylamino hydroxybenzoyl hexyl benzoate (I) are employed in step (c) in at least one form selected from a solid crystalline mass and a suspension in a solvent.
In a preferred embodiment, the seed crystals of diethylamino hydroxybenzoyl hexyl benzoate (I) are employed in step (c) in the form of a suspension in the crystallization solvent in step (a).
In a more preferred embodiment, the seed crystals of diethylamino hydroxybenzoyl hexyl benzoate (I) are employed in step (c) in the form of a suspension in 1-hexanol.
In a preferred embodiment, the amount of the seed crystals is in the range of 0.1 to 15.0 wt %, more preferably in the range of 0.5 to 10.0 wt %, even more preferably in the range of 1.0 to 5.0 wt % and most preferably in the range of 1.5 to 4.5 wt %, based on the weight of diethylamino hydroxybenzoyl hexyl benzoate (I).
In a preferred embodiment, the amount of the seed crystals is 1.5 wt % based on the weight of diethylamino hydroxybenzoyl hexyl benzoate (I) in the solution.
In a preferred embodiment, the amount of the seed crystals is 3.6 wt % based on the weight of diethylamino hydroxybenzoyl hexyl benzoate (I) in the solution.
In a preferred embodiment, after seeding, the supersaturated solution comprising seed crystals is agitated for 1 to 8 hours, more preferably for 2 to 6 hours and most preferably for 3 to 4 hours.
In a preferred embodiment, step (d) involves cooling the solution obtained in step (c) −10 to 15° C.; more preferably to −5 to 10° C. and most preferably to 0 to 5° C.
In a preferred embodiment, in step (d) the solution is cooled to 0° C.
In a preferred embodiment, step (d) involves cooling the solution obtained in step (c) at a cooling rate of 1 to 15° C./h, more preferably at 3 to 10° C./h and most preferably at 3 to 8° C./h.
In a preferred embodiment, in step (d) the solution is cooled at a cooling rate of 5° C./h.
In a preferred embodiment, in step (d) the solution is cooled in a linear manner.
In a preferred embodiment, in step (d) the solution is cooled with a piecewise linear cooling profile.
In a preferred embodiment, in step (d) the solution is cooled with a parabolic cooling profile with increasing cooling rates.
In a preferred embodiment, in step (d) the solution is cooled with a dynamic cooling profile to maintain a relatively constant supersaturation in the crystallizer.
In a preferred embodiment, in step (d) the solution is cooled with vacuum cooling method.
In a preferred embodiment, in step (d) the separation of crystals is carried out by filtration while maintaining the temperature of the solution within ±5° C. of the temperature to which the solution is cooled in step (d).
In a preferred embodiment, step (d) further comprises a step of washing the separated crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) with a washing solvent.
In a preferred embodiment, the washing of the separated crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) is carried out with a washing solvent having a temperature within ±5° C. of the temperature to which the solution is cooled in step (d).
In a preferred embodiment, the washing solvent is at least one selected from the crystallization solvent used in step (a), the feed and a saturated solution of (I) in the solvent used in step (a).
In a preferred embodiment, the washing solvent is the crystallization solvent used in step (a).
In a preferred embodiment, the washing solvent is cooled to a temperature in the range of −5 to 5° C.
In a preferred embodiment, the method of the presently claimed invention further comprises the following steps,
In a preferred embodiment, the crystallization is carried out in a crystallizer selected from a stirred vessel with baffles, force circulation crystallizer, draft tube crystallizer, draft tube baffled crystallizer, and an Oslo type crystallizer.
The method of the presently claimed invention provides crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) with a yield of 85.0 to 99.5%, more preferably 90.0 to 99.0% based on the total of (I) in the feed.
The crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) obtained by the method of the presently claimed invention has a phthalic acid dihexyl ester (PSDHE) (II) content in the range of 1 to 250 ppm, preferably in the range of 1 to 200 ppm, more preferably in the range of 1 to 150 ppm, even more preferably in the range of 1 to 100 ppm, even more preferably in the range of 1 to 50 ppm, most preferably in the range of 1 to 25 ppm and in particular preferably in the range of 1 to 10 ppm based on the weight of the crystalline diethylamino hydroxybenzoyl hexyl benzoate (I).
The method of the presently claimed invention provides crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) having
The crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) obtained by the method of the presently claimed invention has a phthalic acid dihexyl ester (PSDHE) (II) content in the range of 1 to 250 ppm, preferably in the range of 1 to 200 ppm, more preferably in the range of 1 to 150 ppm, even more preferably in the range of 1 to 100 ppm, even more preferably in the range of 1 to 50 ppm, most preferably in the range of 1 to 25 ppm and in particular preferably in the range of 1 to 10 ppm based on the weight of the crystalline diethylamino hydroxybenzoyl hexyl benzoate (I).
The crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) obtained has a rhodamine (Ill) content in the range of 1 to 100 ppm, more preferably in the range of 1 to 80 ppm, even more preferably in the range of 1 to 50 ppm, most preferably in the range of 1 to 25 ppm and in particular preferably in the range of 1 to 10 ppm based on the weight of the crystalline diethylamino hydroxybenzoyl hexyl benzoate (I).
The crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) obtained has a rhodamine hexyl ester (IV) content in the range of 1 to 120 ppm, more preferably in the range of 1 to 100 ppm, even more preferably in the range of 1 to 80 ppm, even more preferably in the range of 1 to 50 ppm, most preferably in the range of 1 to 25 ppm and in particular preferably in the range of 1 to 10 ppm based on the weight of the crystalline diethylamino hydroxybenzoyl hexyl benzoate (I).
The process of the presently claimed invention provides crystalline material having a narrow size distribution. The crystals are uniform, and the crystalline mass obtained has a low amount of fines.
High resolution photographs of the crystalline mass of (I) obtained with the process of WO 03097578 and that obtained by the process of the presently claimed invention are shown in
A uniform crystalline mass is desired since it provides various advantages such as ease of formulation and better performance of cosmetic composition comprising the product.
Due to the low amount of fines, crystalline (I) can be separated from the mother liquor at a high filtration rate with lower incidence of filter clogging during manufacturing.
Advantageously, an early start of crystallization on account of seeding and a faster filtration due to lower amount of fines results in a reduction in batch time for the process. Such reduction in batch time translate in significant economic advantage in industry.
Another aspect of the presently claimed invention is directed to crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) obtained by the method as described above, having
Another aspect of the presently claimed invention is directed to a cosmetic composition comprising crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) and a carrier, wherein the crystalline diethylamino hydroxybenzoyl hexyl benzoate (I) has
In a preferred embodiment, the cosmetic composition further comprises additives and adjuvants.
In a preferred embodiment, the cosmetic composition can be in the form of creams, gels, lotions, alcoholic and aqueous/alcoholic solutions, emulsions, wax/fat compositions, stick preparations, powders or ointments.
In a preferred embodiment, the cosmetic composition further comprises adjuvants and additives selected from mild surfactants, super-fatting agents, pearlescent waxes, consistency regulators, thickeners, polymers, silicone compounds, fats, waxes, stabilisers, biogenic active ingredients, deodorising active ingredients, anti-dandruff agents, film formers, swelling agents, antioxidants, hydrotropic agents, preservatives, insect repellents, self-tanning agents, solubilizers, perfume oils, colorants, bacteria-inhibiting agents and the like.
In a preferred embodiment, the cosmetic compositions according to the presently claimed invention may further comprise as adjuvants, anti-foams, structurants, solubilizers, opacifiers, complexing agents, propellants, coupler and developer components as oxidation dye precursors, reducing agents and oxidizing agents.
In a preferred embodiment, the cosmetic compositions are contained in a wide variety of cosmetic preparations, especially the following preparations:
Yet another aspect of the presently claimed invention is directed to the use of the crystalline 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I) obtained according to the claimed process as UV filter in a cosmetic composition.
The presently claimed invention offers one or more of the following advantages:
In the following, there is provided a list of embodiments to further illustrate the present disclosure without intending to limit the disclosure to the specific embodiments listed below.
While the presently claimed invention has been described in terms of its specific embodiments, certain modifications and equivalents will be apparent to those skilled in the art and are intended to be included within the scope of the presently claimed invention.
The presently claimed invention is illustrated in detail by non-restrictive working examples which follow. More particularly, the test methods specified hereinafter are part of the general disclosure of the application and are not restricted to the specific working examples.
General
2-(4′-Diethylamino-2′-hydroxybenzoyl) benzoic acid hexyl ester (I) in hexanol was prepared according to US20050165099, example 2.
The product obtained from the process was subjected to crystallization as described in the experiments.
Methods
HPLC method for determination of 2-(4′-diethylamino-2′-hydroxybenzoyl) benzoic acid hexyl ester (I), phthalate esters (II), and rhodamine type compounds (Ill) and (IV) have been performed by standard state of the art methods.
GC method for determination of phthalate esters and solvent residues have been performed by standard state of the art methods.
Analytical standards for calibration have been performed by standard state of the art methods.
The equilibrium solubility of (I) in 1-hexanol at different temperatures was determined using a double jacketed 750 mL crystallizer. A mixture of (I) and 1-hexanol in the crystallizer was heated to a target temperature and the equilibrium condition was allowed to establish at that temperature. Samples from the solid free mother liquor were drawn using a filter frit. The samples were analysed for (I) content.
The results are shown in Error! Reference source not found.1 and are plotted in
664.3 g of feed comprising 49.0 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester in hexanol containing 0.74 wt % di-n-hexylphthalate, 0.14 wt % rhodamine and 0.32 wt % rhodamine-hexyl ester corresponding to 14847 ppm di-n-hexylpthalate, 2786 ppm rhodamine and 6397 ppm rhodamine-hexylester calculated on 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (s. above) was charged to a 1.6 L reactor.
The feed was heated at 40° C. to obtain a solution. The solution was cooled to 20° C. within 1.3 h to obtain a supersaturated solution having a c:c* ratio of 5.4.
After 4 h at 20° C. crystallization started. The suspension was stirred at 20° C. overnight (12 h), further cooled to 0° C. within 4 h and stirred at 0° C. The product was filtered off and washed with a portion of 183 g pre-cooled (0° C.) 1-hexanol and followed by another portion of 200 g pre-cooled (0° C.) 1-hexanol to provide 371.5 g hexanol-wet 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester with a content of 80.6 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester.
Byproducts content calculated on the basis of (I): 110 ppm rhodamine, 131 ppm rhodamine-hexylester and 271 ppm di-n-hexylphthalate.
605.6 g of feed comprising 45.0 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester in hexanol containing 0.71 wt % di-n-hexylphthalate, 0.06 wt % rhodamine and 0.33 wt % rhodamine-hexylester corresponding to 15546 ppm di-n-hexylpthalate, 1298 ppm rhodamine and 7292 ppm rhodamine-hexylester calculated on 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester were charged to a 1.6 l reactor and the feed was heated at 40° C. to obtain a solution.
The solution was cooled to 20° C. within 1 h to obtain a supersaturated solution having a c:c* ratio of c:c* 5.0.
Crystallization started after 3.5 h at 20° C. The mixture was stirred for one more hour at 20° C. followed by cooling to 0° C. within 4 h and stirred at 0° C. The product was filtered off and washed with a first portion of 169 g pre-cooled (0° C.) 1-hexanol followed by a second portion of 183 g pre-cooled (0° C.) 1-hexanol to provide 310.9 g hexanol-wet 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester with a content of 79.1 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester.
Byproducts content calculated on the basis of (I): 73 ppm rhodamine, 187 ppm rhodamine-hexylester and 344 ppm di-n-hexylphthalate.
The process parameters and the results of comparative examples 1 and 2 are summarized in Table 2.
Crystallization According to the Present Invention
589.0 g of feed comprising 49.0 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester in hexanol containing 0.74 wt % di-n-hexylphthalate, 0.14 wt % rhodamine and 0.32 wt % rhodamine-hexylester corresponding to 14847 ppm di-n-hexylpthalate, 2786 ppm rhodamine and 6397 ppm rhodamine-hexylester calculated on 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (s. above) was charged to a 1.6 L reactor and the feed was heated at 49° C. to obtain a solution.
The solution was cooled to 25° C. within 1.5 h to obtain a supersaturated solution having c:c* ratio of 4.1.
The supersaturated solution was seeded with 12.3 g (3.6 wt %) 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (84.3 wt %) followed by stirring for 3.4 h at 25° C. The suspension was further cooled to 0° C. within 5 h and stirred at 0° C. The product was filtered off and washed with a first portion of 162 g pre-cooled 1-hexanol (0° C.) followed by a second portion of 177 g pre-cooled 1-hexanol (0° C.) to provide 338 g hexanol-wet 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I) with a content of 80.2 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (I).
Byproducts content calculated on basis of (I): 60 ppm rhodamine, 67 ppm rhodamine-hexylester and 68 ppm di-n-hexylphthalate.
601.8 g of feed comprising 45.0 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester in hexanol containing 0.71 wt % di-n-hexylphthalate, 0.06 wt % rhodamine and 0.33 wt % rhodamine-hexylester corresponding to 15546 ppm di-n-hexylpthalate, 1298 ppm rhodamine and 7292 ppm rhodamine-hexylester calculated on 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (s. above) was charged to a 1.6 L reactor and the feed was heated at 60° C. to obtain a solution.
The solution was cooled to 25° C. within 1 h to obtain a supersaturated solution having c:c* ratio of 3.8.
The supersaturated solution was seeded with 11 g (3.5 wt %) hexanol wet 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (86.7 wt %) followed by stirring for 3.5 h at 25° C.
The solution was cooled to 0° C. within 5 h and stirred at 0° C. The product was filtered off and washed with a first portion of 168 g pre-cooled (0° C.) 1-hexanol followed by a second portion of 182 g pre-cooled (0° C.) hexanol to provide 306.4 g hexanol-wet 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester with a content of 82.1 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester.
Byproducts content calculated on (I): 30 ppm rhodamine, 105 ppm rhodamine-hexylester and 82 ppm di-n-hexylphthalate.
It is clear that the amount of impurities (II), (Ill) and (IV) in crystalline (I) obtained by the process of the presently claimed invention is low as compared to that obtained by the comparative examples.
The method used for crystallization of Examples P3-P11 was similar to method used for the crystallization for Example P1 according to of the presently claimed invention.
The process parameters and the results of examples P1 to P11 are summarized in Table 3.
Recrystallization
180.0 g of the hexanol wet filter cake obtained from C1 comprising 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (80.6 wt %) and 120 g hexanol (48.4 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester in hexanol) was charged to a 1.6 l reactor and the feed was heated at 40° C. to obtain a solution.
The solution was cooled to 25° C. within 1.5 h to obtain a supersaturated solution having c:c* ratio of 4.1.
The supersaturated solution was seeded with 6.3 g (3.7 wt %) 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (84.3 wt %) followed by stirring for 3.6 h at 25° C. The suspension was further cooled to 0° C. within 5 h and stirred at 0° C. The suspension was filtered and the product washed with a first portion of 81 g pre-cooled (0° C.) 1-hexanol and 89 g pre-cooled (0° C.) 1-hexanol to provide 166.7 g hexanol-wet 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester with a content of 79.0 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester.
Byproducts content cal. on (I): 14 ppm rhodamine, 5 ppm rhodamine-hexylester and 12 ppm di-n-hexylphthalate.
201.5 g of hexanol wet feed comprising 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (88.9 wt %) containing 44 ppm rhodamine, 121 ppm rhodamine-hexylester and 165 ppm di-n-hexylphthalate calculated on 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (s. above) and 172 g hexanol (48.0 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester in hexanol) was charged to a 1.6 l reactor and the feed was heated to 49° C. to obtain a solution.
The solution was cooled to 25° C. within 1.5 h to obtain a supersaturated solution having c:c* ratio of 4.0.
The supersaturated solution was seeded with 6.8 g (3.2 wt %) 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester (84.3 wt %) followed by stirring for 3.6 h at 25° C. The suspension was further cooled to 0° C. within 5 h and stirred at 0° C. The suspension was filtered and the product washed with a first portion of 105 g pre-cooled (0° C.) 1-hexanol and a second portion of 115 g pre-cooled (0° C.) 1-hexanol to provide 187 g hexanol-wet 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester with a content of 82.5 wt % 2-(4′-diethylamino-2′-hydroxybenzoyl)benzoic acid hexyl ester.
Byproducts content calculated on the basis of 100% (I): 4 ppm rhodamine, 4 ppm rhodamine-hexylester and 4.5 ppm di-n-hexylphthalate.
The method used for crystallization of Examples R3 and R4 was similar to method used for the crystallization for Example R2 according to of the presently claimed invention.
The process parameters and the results of examples R1 to R4 are summarized in Table 4.
| Number | Date | Country | Kind |
|---|---|---|---|
| 20215330.0 | Dec 2020 | EP | regional |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2021/086103 | 12/16/2021 | WO |
